| SC 13G/A | 2024-03-11 | FMR LLC | Oric Pharmaceuticals, Inc. | 5,094,729 | 7.6% | EDGAR |
| SC 13G/A | 2024-02-14 | EcoR1 Capital, LLC | Oric Pharmaceuticals, Inc. | 6,275,210 | 8.9% | EDGAR |
| SC 13G/A | 2024-02-13 | ALKEON CAPITAL MANAGEMENT LLC | Oric Pharmaceuticals, Inc. | 3,604,096 | 6.6% | EDGAR |
| SC 13G/A | 2024-02-13 | Prosight Management, LP | Oric Pharmaceuticals, Inc. | 1,578,263 | 2.9% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Oric Pharmaceuticals, Inc. | 7,002,108 | 12.8% | EDGAR |
| SC 13G/A | 2024-02-07 | BlackRock Inc. | Oric Pharmaceuticals, Inc. | 2,995,032 | 4.5% | EDGAR |
| SC 13G/A | 2024-02-06 | MILLENNIUM MANAGEMENT LLC | Oric Pharmaceuticals, Inc. | - | 0.0% | EDGAR |
| SC 13G | 2024-02-01 | Venrock Healthcare Capital Partners III, L.P. | Oric Pharmaceuticals, Inc. | 4,428,385 | 6.6% | EDGAR |
| SC 13G | 2024-01-30 | VIKING GLOBAL INVESTORS LP | Oric Pharmaceuticals, Inc. | 4,000,000 | 5.9% | EDGAR |
| SC 13G | 2024-01-29 | BlackRock Inc. | Oric Pharmaceuticals, Inc. | 3,095,648 | 5.7% | EDGAR |
| SC 13G | 2024-01-25 | Frazier Life Sciences Public Fund, L.P. | Oric Pharmaceuticals, Inc. | 1,778,989 | 2.7% | EDGAR |
| SC 13G | 2023-07-07 | Nextech Crossover I GP S.a r.l. | Oric Pharmaceuticals, Inc. | 4,285,714 | 7.9% | EDGAR |
| SC 13G | 2023-06-12 | Prosight Management, LP | Oric Pharmaceuticals, Inc. | 2,280,778 | 5.1% | EDGAR |
| SC 13G/A | 2023-02-13 | ALKEON CAPITAL MANAGEMENT LLC | Oric Pharmaceuticals, Inc. | 2,399,252 | 6.1% | EDGAR |
| SC 13G/A | 2023-02-10 | EcoR1 Capital, LLC | Oric Pharmaceuticals, Inc. | 3,418,068 | 7.6% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Oric Pharmaceuticals, Inc. | 4,016,608 | 10.1% | EDGAR |
| SC 13G/A | 2023-02-06 | VICTORY CAPITAL MANAGEMENT INC | Oric Pharmaceuticals, Inc. | 3,459 | 0.0% | EDGAR |
| SC 13G | 2023-01-20 | MILLENNIUM MANAGEMENT LLC | Oric Pharmaceuticals, Inc. | 2,433,850 | 5.4% | EDGAR |
| SC 13G | 2022-12-29 | PFIZER INC | Oric Pharmaceuticals, Inc. | - | 12.0% | EDGAR |
| SC 13D/A | 2022-12-27 | ORBIMED ADVISORS LLC | Oric Pharmaceuticals, Inc. | 1,787,568 | 4.5% | EDGAR |